Alice Park is the senior health correspondent with TIME, covering the COVID-19 pandemic, new drug developments in cancer and Alzheimer's disease, mental health, HIV, and gene editing technology CRISPR and advances in gene therapy, among other issues in health and science. She also contributes to the magazine’s Olympics coverage, covering figure skating, gymnastics and swimming and co-chaired TIME's inaugural TIME 100 Health Summit in 2019. Her work has won awards from the New York Press Club, and recognition from the Deadline Club.

Park has appeared on CNN, BBC America, National Public Radio and "Good Morning America," and has served on and hosted panels exploring public health issues, cancer, neuroscience and the role of the media in reporting medical news. She is the author of "The Stem Cell Hope, How Stem Cell Medicine Can Change Our Lives."

Milken Institute, Journalism, Health, COVID-19, Cancer, Alzheimer's Disease, Alzheimers, HIV & AIDS, Mental Health, Gene Therapy, Medicine, Authors, Stem Cell Research, Public Health, Aspen Health Reporting, News & Media,